Alcohol and Acute-on-Chronic Liver Failure

Area of Science:

• Hepatology
• Internal Medicine
• Critical Care Medicine

Background:

• Alcoholic hepatitis (AH) is a common cause of chronic liver disease.
• Acute-on-chronic liver failure (ACLF) is a severe complication of AH, characterized by organ failure and high mortality.
• ACLF in AH involves immune dysfunction, systemic inflammation, and increased infection risk.

Purpose of the Study:

• To review the pathophysiology, clinical implications, and management strategies of ACLF in AH.
• To highlight the importance of ACLF diagnosis and prognostic scores in severe AH.
• To discuss current and emerging therapeutic targets and challenges in liver transplantation for AH and ACLF.

Main Methods:

• This is a review article, synthesizing existing knowledge on ACLF in AH.
• Literature review focusing on pathophysiology, diagnosis, prognosis, and treatment of ACLF in AH.
• Discussion of clinical implications, including prognostic scores and therapeutic interventions.

Main Results:

• ACLF significantly worsens the prognosis of AH, with high short-term mortality.
• Corticosteroids are first-line for severe AH but may be insufficient for ACLF.
• Novel therapies targeting inflammation and infection are under investigation.
• Liver transplantation is a key therapy, but organ allocation is a challenge.

Conclusions:

• Understanding ACLF in AH is essential for hepatologists to improve patient management.
• Accurate diagnosis and prognostic scoring are vital for guiding treatment decisions in severe AH with organ failure.
• Further research into novel therapies and optimized organ allocation is needed for severe AH and ACLF.